2013
DOI: 10.1016/j.etap.2013.02.011
|View full text |Cite
|
Sign up to set email alerts
|

Gallic acid: Molecular rival of cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
186
0
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 289 publications
(191 citation statements)
references
References 159 publications
4
186
0
1
Order By: Relevance
“…Gallic acid has also induced apoptosis of colon adenocarcinoma cells [31]. On the other hand, gallic acid has also dose dependent pro-oxidant activity together with metals [32]. In accordance with this, in our results, H5 triggered expressions of SOD slightly more than H10 in healthy cells while the others were statistically equal.…”
Section: Discussionsupporting
confidence: 81%
“…Gallic acid has also induced apoptosis of colon adenocarcinoma cells [31]. On the other hand, gallic acid has also dose dependent pro-oxidant activity together with metals [32]. In accordance with this, in our results, H5 triggered expressions of SOD slightly more than H10 in healthy cells while the others were statistically equal.…”
Section: Discussionsupporting
confidence: 81%
“…Phenolic acid has a strong anti-inflammatory, antimutagenic, and antitumor action, inhibiting genes related to the cell cycle, metastasis, angiogenesis, and apoptosis (Verma et al, 2013). The detection of three types of flavonoids, catechin, naringin, and quercetin, in the L. sidoides plant ( Figure 2B) also allows presenting and confirm the possibility of harnessing its leaves for biological applications.…”
Section: Discussionmentioning
confidence: 88%
“…Hu (2011) reported that pro-oxidant activity can be demonstrated by small phenolics, such as gallic acid, which are easily oxidized and thereby mobilize cellular copper ions or decrease cellular-reduced glutathione. Gallic acid has been identified as both a pro-oxidant and an antioxidant that could cause a dose-dependent reduction of the intracellular GSH level (Verma et al 2013;Chang et al 2015). Furthermore, as most xenobiotics, polyphenols also undergo phase I and II metabolism.…”
Section: Discussionmentioning
confidence: 99%